Ergothioneine and exercise: A match made in (cognitive) heaven?
Ageing Research Reviews · 2026
DOI: 10.1016/j.arr.2025.102993 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2026. Verfasst von Vanessa Kristina Wazny und 4 weiteren Autor:innen. Beteiligte Einrichtung: NUS Academy for Healthy Longevity, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Hauptthemen laut MEDLINE: Ergothioneine, Exercise, Cognition, Antioxidants. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Universidad de Castilla-La Mancha, European Social Fund Plus.
Abstract (Originalsprache)
Cognitive decline is one of the key challenges with aging, with significant implications for independence, quality of life, and healthcare burden. As pharmacological treatments remain limited in efficacy and often carry adverse effects, there is growing interest in safe, accessible, non-pharmacological strategies to preserve cognitive function. This Short Review explores the potential of combining two approaches that, individually, have shown beneficial effects on cognitive function: ergothioneine, a naturally occurring amino acid with antioxidant and anti-inflammatory properties, and physical exercise. Ergothioneine accumulates in the brain and other high-stress organs, where it modulates the redox balance, dampens chronic inflammation and supports mitochondrial function. Meanwhile, physical exercise has well-documented benefits for neuroplasticity, cerebral perfusion, and cognitive performance. Preclinical studies suggest ergothioneine supports exercise performance and muscle recovery without attenuating adaptive responses. Despite their distinct and complementary mechanisms, currently there are no available studies exploring the combined effects of ergothioneine and exercise on cognition. We propose a future research agenda that includes mechanistic animal studies, dose-response trials, and clinical interventions in at-risk populations. Together, the combination of ergothioneine and exercise may offer a low-risk, multifaceted approach to enhancing cognitive resilience in aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NUS Academy for Healthy Longevity, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- NUS Academy for Healthy Longevity, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Department of Sports Science and Physical Education, The Chinese University of Hong Kong, Hong…
- Department of Systems Biology, University of Alcalá, Madrid, Spain; GENUD Toledo Research Group, Faculty of Sport Sciences, University of Castilla-La Mancha, Toledo, Spain; Centro de Investigación Biomédica en Red Fragi…
- Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Department of Psychological Medicine, Yong Loo Lin School of Medicine, Nationa…
- NUS Academy for Healthy Longevity, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National U…
Förderung
- Universidad de Castilla-La Mancha
- European Social Fund Plus
Zitieren
APA
Wazny, V. K., Grgic, J., Valenzuela, P. L., Feng, L., & Maier, A. B. (2026). Ergothioneine and exercise: A match made in (cognitive) heaven?. Ageing Research Reviews. https://doi.org/10.1016/j.arr.2025.102993
Vancouver
Wazny VK, Grgic J, Valenzuela PL, Feng L, Maier AB. Ergothioneine and exercise: A match made in (cognitive) heaven?. Ageing Research Reviews. 2026. doi:10.1016/j.arr.2025.102993
BibTeX
@article{Wazny2026,
author = {Wazny, Vanessa Kristina and Grgic, Jozo and Valenzuela, Pedro L and Feng, Lei and Maier, Andrea B},
title = {Ergothioneine and exercise: A match made in (cognitive) heaven?},
journal = {Ageing Research Reviews},
year = {2026},
doi = {10.1016/j.arr.2025.102993}
}
EUVIMED